Screening for α-glucosidase (α-GLU) inhibitors is vital for the discovery of antidiabetic drugs, and traditional Chinese herbal medicines (TCMs) are promising antidiabetic agents. However, traditional high-throughput screening strategies are labor intensive. The integration of nanozymes with machine learning provides prospects for convenient and highly efficient screening strategies. To advance this status, a dual-active MnO2-decorated Ce metal−organic framework nanozyme (MnPCe) with outstanding oxidase-like (OXD-like) and laccase-like (LAC-like) activity was synthesized for the first time. After the conjugation of MnO2 on CeMOF, the OXD-like and LAC-like activities of MnPCe increased. Inspired by the cascade reaction and signal complementarity between the dual-active MnPCe nanozyme and natural α-GLU, a machine learning-assisted triple-channel biosensor array for α-GLU inhibitors was constructed based on the combination of the nanozyme and natural enzyme catalytic channels. The three colorimetric signals were integrated into a unique fingerprint pattern, enabling the sensor array to accurately discriminate nine common α-GLU inhibitors. It also successfully distinguished TCMs containing different types of α-GLU inhibitors, highlighting its potential for high-throughput screening of antidiabetic agents from complex herbal matrices. It inspires the innovation of multifunctional nanozymes, the development of high-throughput screening of promising drugs, and the extraction of valuable compounds from herbal medicines.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: